Investigating the Effects of Cognitive Functional Therapy on Pain, Physical Function, and Kinesiophobia in Individuals With Chronic Ankle Sprain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorYeditepe University

About this trial

The aim of this study is to investigate the effects of Cognitive Functional Therapy (CFT) on pain, physical function, and kinesiophobia in individuals with chronic ankle sprain (CAS).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Ongoing pain or swelling, "giving way" episodes, and re-injury during sports or daily activity

Adults aged 18-65 years

History of lateral ankle sprain with symptoms persisting for more than 3 months

Continuing symptoms such as pain, instability, or activity limitations

Disqualifiers

History of ankle surgery within the past 12 months

Advanced ankle osteoarthritis or systemic inflammatory, neurological, or vestibular conditions

Currently undergoing physiotherapy for the same condition

Cognitive impairment or severe psychological disorder that could interfere with participation

Trial design

Design model

Single group

Treatments tested in this trial

  • Cognitive Functional Therapy

    Procedure/Surgery

    Cognitive Functional Therapy is an integrated behavioral approach for individualizing the management of people with chronic pain, originally developed for Low Back Pain Patients. It uses a multidimensional "clinical reasoning framework" to identify key modifiable targets for management on the basis of careful listening to the individual's story and examining the individual's behavioral responses to pain. This approach enables the treating clinician to take individuals on a journey to effectively self-manage their chronic pain with a program that is tailored to their unique clinical presentation and context.

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: Cognitive Functional Therapy GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

FAAM

Foot and Ankle Ability Measure

Time frame
12 Weeks
2

TSK-17

Tampa Scale of Kinesiophobia

Time frame
12 Weeks
3

VAS

Visual Analogue Scale

Time frame
12 Weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.